RT Journal Article
SR Electronic
T1 Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 285
DO 10.1186/s40425-019-0792-9
VO 7
IS 1
A1 Florou, Vaia
A1 Rosenberg, Andrew E.
A1 Wieder, Eric
A1 Komanduri, Krishna V.
A1 Kolonias, Despina
A1 Uduman, Mohamed
A1 Castle, John C.
A1 Buell, Jennifer S.
A1 Trent, Jonathan C.
A1 Wilky, Breelyn A.
YR 2019
UL http://jitc.bmj.com/content/7/1/285.abstract
AB Following publication of the original article [1], the authors have reported that the following sentence “While of the same IgG1 class as ipilimumab, preclinical data suggests this molecule may have enhanced activity against T regulatory cells”.The original article can be found online at 10.1186/s40425-019-0689-7